A carregar...
Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
Metastatic breast cancer (MBC) remains an incurable disease, with the goals of care aimed at maximizing the patient’s duration and quality of life. Treatment options for MBC have become more efficacious and numerous. In addition to endocrine and chemotherapy agents, a number of targeted agents, incl...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3233277/ https://ncbi.nlm.nih.gov/pubmed/22162924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S16392 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|